The pharmacological treatment of hyperuricemia is primarily categorized into three groups: xanthine oxidase inhibitors (XOIs), urate-lowering therapies that target urate anion exchange transporters, and uricase-like agents. The gene discussed is XDH; the disease is hyperuricemia.